SEID Lab (formally SEID S.A. or Laboratorios SEID) is a Spanish pharmaceutical company with over 60 years of experience, specialized in the development, manufacture, and marketing of healthcare products for women and their families. Established in 1958 and headquartered in Lliçà de Vall, Barcelona, the company has evolved from a general pharmaceutical lab into a leader in the field of gynecology and reproductive health.
Core Focus and Specialization
Since 1990, SEID Lab has focused its research and development (R&D) and commercial efforts primarily on gynecology, covering various stages of a woman’s life:
Fertility and Pregnancy:
Providing solutions for conception and prenatal care, including flagship products like Seidivid®, Seidibion®, and Seidiferty®.
Menopause:
Developing products to relieve menopausal symptoms and support bone health, such as Menocta®.
Intimate Health:
Offering treatments for infections and general well-being, including the Seidigyn® line for intimate care and CISTISEID® for preventing recurrent cystitis.
Traditional Medicine:
Maintaining its legacy brands for wound care (Furacin®) and gout treatment (Colchicine SEID®).
Manufacturing and Services
SEID Lab operates as both a proprietary manufacturer and a Contract Manufacturing Organization (CMO):
Facilities:
Its plant in Barcelona is authorized for the manufacture, packaging, and distribution of medicinal products, medical devices, and food supplements.
Dosage Forms:
The company specializes in various solid, granulated, suspension, and semisolid forms, including hormonal semisolids.
Quality Standards:
All processes follow Good Manufacturing Practices (GMP) and undergo exhaustive quality controls, including physical-chemical, microbiological, and stability testing.
Pharmacy Unit:
In 2021, the company launched its Pharmacy Unit (Seidypharm) to address the growing self-care needs of women and their families directly through pharmaceutical recommendations.
Key Historical Milestones
1958:
Founding of Laboratorios SEID.
1970s:
Focus on early products Furacin® and Colchicine®.
1990:
Specialization in gynecology begins with the launch of Progesterone.
2010:
Established leadership in fertility and pregnancy markets.
2013:
Expanded into third-party contract manufacturing (CMO).
2021:
Launch of the Seidypharm range for pharmaceutical recommendations.
Corporate Mission and Strategy
SEID Lab’s mission is to support healthcare professionals by providing effective therapeutic solutions that improve the quality of life for women and their families. While historically driven by medical prescriptions, the company is also expanding its presence in the direct pharmacy market in Spain, leveraging the recommendation power of pharmacists.